skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: JSTOR Early Journal Content Free remover Base de dados/Biblioteca: Oxford Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection

Flynn, Neil M ; Forthal, Donald N ; Harro, Clayton D ; Judson, Franklyn N ; Mayer, Kenneth H ; Para, Michael F

The Journal of infectious diseases, 2005-03, Vol.191 (5), p.654-665 [Periódico revisado por pares]

United States: The University of Chicago Press

Texto completo disponível

Citações Citado por
2
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Kalams, Spyros A. ; Parker, Scott D. ; Elizaga, Marnie ; Metch, Barbara ; Edupuganti, Srilatha ; Hural, John ; De Rosa, Stephen ; Carter, Donald K. ; Rybczyk, Kyle ; Frank, Ian ; Fuchs, Jonathan ; Koblin, Beryl ; Kim, Denny H. ; Joseph, Patrice ; Keefer, Michael C. ; Baden, Lindsey R. ; Eldridge, John ; Boyer, Jean ; Sherwat, Adam ; Cardinali, Massimo ; Allen, Mary ; Pensiero, Michael ; Butler, Chris ; Khan, Amir S. ; Yan, Jian ; Sardesai, Niranjan Y. ; Kublin, James G. ; Weiner, David B.

The Journal of infectious diseases, 2013-09, Vol.208 (5), p.818-829 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV-1 gp120 Vaccines
Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV-1 gp120 Vaccines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV-1 gp120 Vaccines

Montefiori, David C. ; Metch, Barbara ; McElrath, M. Juliana ; Self, Steve ; Weinhold, Kent J. ; Corey, Lawrence

The Journal of infectious diseases, 2004-12, Vol.190 (11), p.1962-1969 [Periódico revisado por pares]

Chicago, IL: The University of Chicago Press

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.